TY - JOUR
T1 - Understanding the Determinants of Use of the Australian Guide to Diagnosis of Fetal Alcohol Spectrum Disorder
T2 - Informing the Review, Development and Dissemination of New National Clinical Practice Guidelines
AU - The Australian FASD Guidelines Consortium
AU - Reid, Natasha
AU - Logan, Jayden
AU - Wong, Yasmine
AU - Munn, Zachary
AU - Vanderpeet, Chelsea
AU - Hayes, Nicole
AU - Anderson, Storm
AU - Barnett, Diana
AU - Crawford, Andi
AU - Doney, Robyn
AU - Elliott, Elizabeth
AU - Friend, Rowena
AU - Goldsbury, Sarah
AU - Gullo, Matthew
AU - Harrington, Sophie
AU - Harris, Katrina
AU - Hewlett, Nicole
AU - Hutchinson, Delyse
AU - Kay, Fiona
AU - Kippin, Natalie
AU - Middleton, Philippa
AU - Mutch, Raewyn
AU - Naglazas, Max
AU - Padencheri, Seema
AU - Pestell, Carmela
AU - Shelton, Doug
AU - Skorka, Kelly
AU - Stewart, James
AU - Till, Haydn
AU - Walker, Prue
AU - Bagley, Kerryn
AU - Crichton, Alison
AU - Elliott, Elizabeth
AU - Finlay-Jones, Amy
AU - Friend, Rowena
AU - Moritz, Karen
AU - Shanley, Dianne
AU - Till, Haydn
AU - Webster, Andrew
AU - White, Alan
N1 - Publisher Copyright:
© 2025 The Author(s). Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.
PY - 2025/9/7
Y1 - 2025/9/7
N2 - Introduction: The Australian Guide to the Diagnosis of fetal alcohol spectrum disorder (FASD), developed in 2016, is currently under review. This study aimed to understand how the Guide is used in practice and identify factors influencing its implementation. Methods: A cross-sectional online survey was conducted with Australian health practitioners involved in the assessment and diagnosis of FASD. The Clinician Guideline Determinants Questionnaire was used. Quantitative data were summarised descriptively and content analysis was applied to open-ended questions. Results: Of 333 survey sessions, 232 participants consented and 136 completed the survey. Most respondents were paediatricians (n = 54, 37%) or psychologists (n = 49, 33%). Although most clinicians felt confident using the Guide, only 44.1% agreed it clearly described the underlying evidence, and just 21% felt it adequately reflected patient preferences. Key enablers included clear, easy-to-follow guidance (n = 45, 36.3%); ease of access (n = 18, 14.5%) and familiarity with the Guide (n = 14, 11.3%). Common barriers were lack of access to appropriate clinicians, time and cost constraints (n = 25, 24.8%); concerns about the evidence base (n = 16, 15.8%); and lack of familiarity or skills (n = 8, 7.9%). Discussion and Conclusions: Findings highlight strong clinician engagement with the 2016 Guide but also identify areas for improvement, particularly around evidence transparency and alignment with person-centred care. By engaging with stakeholders and improving guidelines based on clinician feedback, we can improve the quality of care and support for individuals with FASD and their families.
AB - Introduction: The Australian Guide to the Diagnosis of fetal alcohol spectrum disorder (FASD), developed in 2016, is currently under review. This study aimed to understand how the Guide is used in practice and identify factors influencing its implementation. Methods: A cross-sectional online survey was conducted with Australian health practitioners involved in the assessment and diagnosis of FASD. The Clinician Guideline Determinants Questionnaire was used. Quantitative data were summarised descriptively and content analysis was applied to open-ended questions. Results: Of 333 survey sessions, 232 participants consented and 136 completed the survey. Most respondents were paediatricians (n = 54, 37%) or psychologists (n = 49, 33%). Although most clinicians felt confident using the Guide, only 44.1% agreed it clearly described the underlying evidence, and just 21% felt it adequately reflected patient preferences. Key enablers included clear, easy-to-follow guidance (n = 45, 36.3%); ease of access (n = 18, 14.5%) and familiarity with the Guide (n = 14, 11.3%). Common barriers were lack of access to appropriate clinicians, time and cost constraints (n = 25, 24.8%); concerns about the evidence base (n = 16, 15.8%); and lack of familiarity or skills (n = 8, 7.9%). Discussion and Conclusions: Findings highlight strong clinician engagement with the 2016 Guide but also identify areas for improvement, particularly around evidence transparency and alignment with person-centred care. By engaging with stakeholders and improving guidelines based on clinician feedback, we can improve the quality of care and support for individuals with FASD and their families.
KW - diagnosis
KW - fetal alcohol spectrum disorders
KW - practice guidelines
KW - surveys and questionnaires
UR - https://www.scopus.com/pages/publications/105015967719
U2 - 10.1111/dar.70030
DO - 10.1111/dar.70030
M3 - Article
C2 - 40916487
AN - SCOPUS:105015967719
SN - 0959-5236
JO - Drug and Alcohol Review
JF - Drug and Alcohol Review
ER -